Published in

Wiley Open Access, Cancer Medicine, 16(10), p. 5437-5447, 2021

DOI: 10.1002/cam4.4090

Links

Tools

Export citation

Search in Google Scholar

Characterization of response to atezolizumab + bevacizumab versus sorafenib for hepatocellular carcinoma: Results from the IMbrave150 trial

Journal article published in 2021 by Riad Salem ORCID, Daneng Li ORCID, Nicolas Sommer, Sairy Hernandez, Wendy Verret, Beiying Ding, Riccardo Lencioni ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO